 BeyondSpring Inc NASDAQ: BYSI announced new data highlighting the mechanism of action of plinabulin in preventing chemotherapy-induced neutropenia CIN at the American Society of Hematology ASH Annual Meeting and Exposition. The comparison was made between cancer patients receiving plinabulin 40 mg n228 or not receiving plinabulin n172 and with all patients receiving myelosuppressive chemotherapy. 